You are here

Home › COVID shots should target XBB variants in 2023-24 campaign, US FDA staff say › COVID shots should target XBB variants in 2023-24 campaign, US FDA staff say

COVID shots should target XBB variants in 2023-24 campaign, US FDA staff say

Primary tabs

COVID shots should target XBB variants in 2023-24 campaign, US FDA staff say

Mon, 2023-06-12 18:05 — mike kraft
COVID shots should target XBB variants in 2023-24 campaign, US FDA staff say COVID-19 vaccines being developed and manufactured for the 2023-2024 campaign should target one of the currently dominant XBB variants, the U.S. Food and Drug Administration's (FDA) staff reviewers said on Monday. Reuters Reuters

...

The comments were made in documents posted ahead of Thursday's meeting of a panel of FDA's independent experts, who are expected to make recommendations on what strain an updated COVID-19 booster should target.

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Disease Prevention
Mutations
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report
Groups this Group Post belongs to: 
- Private group -
Workflow history
Revision ID Field name Date Old state New state name By Comment Operations
No state No state
howdy folks